LimmaTech Biologics AG’s $37 Million Series A Financing Round

Marco Zingaro Europe Legal Chronicle
Tagged:

VISCHER acted as legal advisor to LimmaTech Biologics in the transaction.LimmaTech Biologics AG closed a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant Capital,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here